2026 Q2 Portfolio Activity
In 2026 Q2, Patient Square Capital LP maintained a portfolio of 35 distinct positions. The most significant new addition was REVOLUTION MEDICINES INC, now representing 8.01% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing the position by 70.3%. Conversely, Patient Square Capital LP completely exited their position in INSMED INC.
Position History
hover any row below to update
Loading…
Patient Square Capital LP
Menlo Park, CA
Private Equity / Healthcare-Focused Investment Firm
AUM $646M
Total Positions
35
Quarter
2026 Q2
Top Holding
ROIV (44.0%)
Top 10 Concentration
80.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-35 of 35
Patient Square Capital LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 43.97% | 40.13% |
#1
Prev: #1
|
6.5 |
—
|
-145,119 | -1.8% |
P
S
|
8,020,928 | $283,860,642 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 8.01% | — |
#2
Prev: #—
|
8.2 |
—
|
276,000 | — |
NEW
|
276,000 | $51,689,280 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 4.72% | 3.77% |
#3
3
Prev: #6
|
4.9 |
—
|
30,500 | 13.3% |
P
S
|
260,500 | $30,496,735 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 4.26% | 2.40% |
#4
8
Prev: #12
|
5.2 |
—
|
85,255 | 70.3% |
P
S
|
206,500 | $27,518,190 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 3.97% | 4.24% |
#5
1
Prev: #4
|
4.1 |
—
|
9,478 | 11.8% |
P
S
|
90,020 | $25,652,999 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 3.60% | 2.47% |
#6
5
Prev: #11
|
3.9 |
—
|
178,209 | 36.1% |
P
S
|
671,209 | $23,210,407 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ARGX
ARGENX SE
|
Healthcare | 3.31% | 4.76% |
#7
5
Prev: #2
|
1.3 |
—
|
-13,718 | -37.4% |
P
S
|
23,000 | $21,338,710 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.12% | — |
#8
Prev: #—
|
4.7 |
—
|
37,120 | — |
NEW
|
37,120 | $20,112,730 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 2.62% | 3.30% |
#9
2
Prev: #7
|
1.5 |
—
|
-6,684 | -5.7% |
P
S
|
110,000 | $16,938,350 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.55% | 4.07% |
#10
5
Prev: #5
|
1.0 |
—
|
-171,000 | -28.7% |
P
S
|
425,000 | $16,447,500 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 2.31% | 2.57% |
#11
1
Prev: #10
|
3.4 |
—
|
215,940 | 31.1% |
P
S
|
909,474 | $14,915,374 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 2.06% | 2.34% |
#12
1
Prev: #13
|
1.3 |
—
|
-7,000 | -3.1% |
P
S
|
220,000 | $13,279,200 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
BNTX
BIONTECH SE
|
Healthcare | 1.94% | — |
#13
Prev: #—
|
4.3 |
—
|
134,429 | — |
NEW
|
134,429 | $12,508,618 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 1.70% | 0.75% |
#14
13
Prev: #27
|
3.7 |
—
|
160,800 | 82.5% |
P
S
|
355,800 | $10,969,314 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 1.67% | 1.39% |
#15
6
Prev: #21
|
2.7 |
—
|
12,500 | 6.2% |
P
S
|
212,500 | $10,784,375 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.63% | 1.40% |
#16
4
Prev: #20
|
2.7 |
—
|
14,118 | 15.0% |
P
S
|
108,000 | $10,527,840 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 1.63% | 1.49% |
#17
1
Prev: #18
|
3.2 |
—
|
1,600,000 | 46.4% |
P
S
|
5,050,000 | $10,504,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 1.59% | 1.82% |
#18
3
Prev: #15
|
1.1 |
—
|
-75,000 | -9.4% |
P
S
|
720,000 | $10,296,000 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 1.50% | 1.67% |
#19
2
Prev: #17
|
1.1 |
—
|
-30,645 | -7.6% |
P
S
|
370,000 | $9,701,400 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CCCC
C4 THERAPEUTICS...
|
Healthcare | 1.16% | — |
#20
Prev: #—
|
4.0 |
—
|
1,608,815 | — |
NEW
|
1,608,815 | $7,513,166 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 1.15% | — |
#21
Prev: #—
|
4.0 |
—
|
1,967,171 | — |
NEW
|
1,967,171 | $7,435,906 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 0.84% | 1.48% |
#22
3
Prev: #19
|
0.3 |
—
|
-52,500 | -52.5% |
P
S
|
47,500 | $5,446,825 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
SNSE
FAETH THERAPEUT...
|
Healthcare | 0.68% | — |
#23
Prev: #—
|
3.8 |
—
|
175,050 | — |
NEW
|
175,050 | $4,376,250 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-1,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 0.00% | 0.67% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-136,315 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.00% | 0.91% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-1,085,790 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 0.00% | 0.95% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-1,030,846 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
HROW
HARROW INC
|
Healthcare | 0.00% | 1.03% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-165,209 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.00% | 1.11% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-331,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CATX
PERSPECTIVE THE...
|
Healthcare | 0.00% | 1.20% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-1,625,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 0.00% | 1.71% |
Sold All 😨
(Was: #16) |
0.0 |
—
|
-80,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.00% | 1.92% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-95,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.00% | 2.68% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-210,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 0.00% | 3.18% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-990,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-12 | |||
|
INSM
INSMED INC
|
Healthcare | 0.00% | 4.57% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-157,500 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-12 |
Showing 1-35 of 35 holdings